Overactive bladder disease: the urge for better therapies

J Manag Care Pharm. 2008 May;14(4):381-6. doi: 10.18553/jmcp.2008.14.4.381.
No abstract available

Publication types

  • Review

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Benzilates
  • Cresols / therapeutic use*
  • Delayed-Action Preparations
  • Female
  • Humans
  • Male
  • Muscarinic Antagonists / adverse effects
  • Muscarinic Antagonists / therapeutic use*
  • Nortropanes / therapeutic use*
  • Parasympatholytics / therapeutic use*
  • Patient Compliance*
  • Phenylpropanolamine / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Tolterodine Tartrate
  • Treatment Outcome
  • Urinary Bladder, Overactive / drug therapy*

Substances

  • Benzhydryl Compounds
  • Benzilates
  • Cresols
  • Delayed-Action Preparations
  • Muscarinic Antagonists
  • Nortropanes
  • Parasympatholytics
  • trospium chloride
  • Phenylpropanolamine
  • Tolterodine Tartrate